These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phenylbutazone, oxyphenbutazone and aplastic anaemia. Böttiger LE Br Med J; 1977 Jul; 2(6081):265. PubMed ID: 884472 [No Abstract] [Full Text] [Related]
4. Phenylbutazone, oxyphenbutazone labeling revised. FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172 [No Abstract] [Full Text] [Related]
5. Aplastic anaemia. II. Drug-induced aplastic anaemia. Böttiger LE; Westerholm B Acta Med Scand; 1972 Oct; 192(4):319-21. PubMed ID: 5081069 [No Abstract] [Full Text] [Related]
6. Phenylbutazone and oxyphenbutazone: time to call a halt. Drug Ther Bull; 1984 Jan; 22(2):5-6. PubMed ID: 6692755 [No Abstract] [Full Text] [Related]
7. [Bone marrow aplasia in the course of anti-epileptic treatments]. Gabriel B; Gabriel BJ; Olmer J Mars Med; 1966; 103(12):935-47. PubMed ID: 5991236 [No Abstract] [Full Text] [Related]
8. Oxyphenbutazone (Tanderil) and blood dyscrasia. Brownlie BE; Strang PJ N Z Med J; 1969 Feb; 69(441):77-9. PubMed ID: 5252205 [No Abstract] [Full Text] [Related]
9. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Inman WH Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part I. Chaplin S Adverse Drug React Acute Poisoning Rev; 1986; 5(2):97-136. PubMed ID: 3529881 [No Abstract] [Full Text] [Related]
12. In vitro evidence of drug action in aplastic anemia. Vincent PC Blut; 1984 Jul; 49(1):3-12. PubMed ID: 6378281 [No Abstract] [Full Text] [Related]
13. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part II. Chaplin S Adverse Drug React Acute Poisoning Rev; 1986; 5(3):181-96. PubMed ID: 3538824 [No Abstract] [Full Text] [Related]
16. Aplastic anaemia. I. Incidence and aetiology. Böttiger LE; Westerholm B Acta Med Scand; 1972 Oct; 192(4):315-8. PubMed ID: 5081068 [No Abstract] [Full Text] [Related]
17. Aplastic anemia in association with gold therapy for rheumatoid arthritis. Gibson J; McGirr EE; York J; Kronenberg H Aust N Z J Med; 1983 Apr; 13(2):130-4. PubMed ID: 6351827 [TBL] [Abstract][Full Text] [Related]
18. Comparison of fenoprofen and oxyphenbutazone in patients with rheumatoid arthritis. Franke M; Manz G Curr Ther Res Clin Exp; 1977 Jan; 21(1):43-9. PubMed ID: 401711 [No Abstract] [Full Text] [Related]
19. Chrysotherapy-induced aplastic anemia: a case report. Shearer CA; Parker WA Am J Hosp Pharm; 1978 Sep; 35(9):1095-9. PubMed ID: 100010 [TBL] [Abstract][Full Text] [Related]
20. [Case of aplastic anemia following treatment with Sanochrysin]. Syc S; Kondrak R; Hulok W Wiad Lek; 1978 Apr; 31(7):479-81. PubMed ID: 664680 [No Abstract] [Full Text] [Related] [Next] [New Search]